18 / 22
Page 57
conferenceseries
.com
Volume 8, Issue 10 (Suppl)
J Diabetes Metab
ISSN: 2155-6156 JDM, an open access journal
Herbal Diabetes 2017
November 02-04, 2017
November 02-04, 2017 Bangkok, Thailand
23
rd
International Conference on
Herbal and Alternative Remedies for
Diabetes and Endocrine Disorders
Prevalence of dyslipidemia and atherogenic risk among type-2 diabetic outpatients in teaching hospital
Odeafo Asamoah-Boakye
Kwame Nkrumah University of Science and Technology, Ghana
D
yslipidemia is major risk factor of cardiovascular diseases and concurrently, CVDs are responsible for 68% cause of
mortality among type-2 diabetes. The study aimed to determine dyslipidemia and atherogenic index, among type-2
diabetic outpatients. A cross-sectional study was conducted. The waist circumference, fasting blood glucose, HbA1c, serum
total cholesterol, triglyceride, high density lipoprotein, low-density lipoprotein, coronary risk and atherogenic index were
determined. Sociodemographic data were collected with questionnaire. Data were analyzed using SPSS version 23. Out of 152
subjects, 37 (24.3%) were males and 115 (75.7%) were females. The prevalence of hyperglycemia was 74.3%. The prevalence
of single dyslipidemia, combined dyslipidemia and mixed dyslipidemia were 63.8%, 15.8% and 1.3%, respectively. Also,
35.3% of subjects had high coronary risk and 5.3% had high atherosclerosis risk. Coronary risk was strongly associated with
TC (r=0.690, p<0.0001) and LDL-C (r=0.783, p<0.0001). Additionally, atherosclerosis risk was strongly associated with TG
(r=0.817, p<0.0001) and VLDL-C, (r=0.817, p<0.0001). Logistic regression showed TC, TG, LDL-C had significant effects
on coronary risk for cardiovascular diseases (TC: OR=2.640, 95% CI=1.879-3.708, p<0.0001, TG: OR=2.549, 95% CI=1.342-
4.841, p=0.004, LDL-C: OR=4.858, 95% CI=2.902-8.135, p<0.0001, respectively). Atherogenic dyslipidemia was high among
type-2 diabetics and was significantly associated with high coronary and atherosclerosis risk. Atherogenic dyslipidemia is
predisposing factor of CVDs among type-2 diabetics, putting them to high risk of mortality.
odeafo2010@yahoo.comJ Diabetes Metab 2017, 8:10 (Suppl)
DOI: 10.4172/2155-6156-C1-073